linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Cohance Lifesciences Ltd.
 
Source DateBoard Meeting DateDetails
29 Sep 202512 Nov 2025 Quarterly Results
27 Jun 202513 Aug 2025 Quarterly Results
26 Mar 202528 May 2025 Audited Results
27 Dec 202412 Feb 2025 Quarterly Results
26 Sep 202412 Nov 2024 Quarterly Results
02 Aug 202409 Aug 2024 Quarterly Results
21 May 202430 May 2024 Audited Results (Revised)
29 Jan 202405 Feb 2024 Quarterly Results
02 Nov 202309 Nov 2023 Quarterly Results
01 Aug 202308 Aug 2023 Quarterly Results
18 May 202325 May 2023 Audited Results
30 Jan 202306 Feb 2023 Quarterly Results
01 Nov 202208 Nov 2022 Quarterly Results
29 Aug 202202 Sep 2022 Interim Dividend
01 Aug 202208 Aug 2022 Quarterly Results
02 May 202209 May 2022 Interim Dividend & Audited Results
01 Feb 202208 Feb 2022 Special Dividend
29 Oct 202106 Nov 2021 Quarterly Results
06 Aug 202113 Aug 2021 Quarterly Results
01 Jun 202108 Jun 2021 Final Dividend & Audited Results
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.